Bind Research launched to transform disordered proteins into effective drug targetsUK’s first not-for-profit Focused Research Organisation ...

Roseman's free agency and draft class from last offseason made contributions in Sunday's Super Bowl win. Nick Sirianni also ...

Companies were unusually optimistic this quarter as fourth-quarter earnings came in strong. Here's why CEOs are hopeful ...

Exane BNP Paribas upgraded Genmab (GMAB) to Neutral from Underperform with a DKK 1,500 price target. The firm sees a “reasonable” valuation at ...

The Blackhawks and Capitals lead the way with seven ranked prospects apiece, followed by the Sharks, Wild and Predators with ...